Updated briefing note on Target 17 (biosafety) of the First Draft of the post-2020 Global Biodiversity Framework. […]
|
||||||
Updated briefing note on Target 17 (biosafety) of the First Draft of the post-2020 Global Biodiversity Framework. […] TWN’s analysis and proposals for Target 17 of the Global Biodiversity Framework, which addresses the issue of biosafety. […] Discussions at the CBD on the assessment of new genetic technologies, such as synthetic biology and organisms containing engineered gene drives have brought to light major differences. […] Formal virtual negotiations under the Convention on Biological Diversity (CBD) have hit major stumbling blocks. This is largely due to the inequities of the virtual format, which have prevented meaningful participation by developing countries, especially the African Group. […] The African Group, at a key meeting of the Convention on Biological Diversity (CBD), has expressed deep regret that because of the virtual setting, representation from the African Parties has been extremely limited. […] The CBD’s Subsidiary Body on Implementation (SBI) held a virtual informal session from 8-12 March and 14 March 2021, covering various aspects related to the implementation of the Convention and its Cartagena and Nagoya Protocols. […] The CBD’s Subsidiary Body on Scientific, Technical and Technological advice is currently holding a virtual informal session (17-19 and 24-26 February 2021). Among the agenda items discussed were that of synthetic biology, and risk assessment and risk management of LMOs. The issue of gene drive organisms features prominently in both these agenda items, with civil society calling for a moratorium on environmental releases of such organisms. […] Amidst recent scientific reports highlighting the biodiversity crisis, new negotiations have begun for crucial implementation of the CBD in the period post-2020. […] Parties to the CBD have approved conflicts of interest procedures to limit the influence of private sector industry and other economic and vested interests from unduly influencing decisions taken to protect biological diversity. […] Parties to the CBD have concluded that the rapid and fast-paced developments in the field of synthetic biology and their potential adverse effects need to be anticipated, monitored and assessed. […] |
||||||
All our content may be republished or reused for free, except where otherwise noted. This site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Powered by WordPress & Atahualpa |